by Jordana Choucair | Jun 8, 2022 | Life Sciences
The Food and Drug Administration’s (FDA) vaccine advisory panel voted to authorize Novavax’s COVID-19 vaccine for use in adults. The panel voted 21-0, with one abstention. Novavax’s two-dose vaccine was about 90 percent effective at preventing mild, moderate, and...
by Jordana Choucair | Jun 7, 2022 | Life Sciences
An investigation conducted by the U.S. Department of Health and Human Services (HHS) Office of the Inspector General (OIG) found that roughly two-thirds of more than 600 biomedical research institutions had violated at least one disclosure agreement The HHS OIG said...
by Jordana Choucair | Jun 7, 2022 | Life Sciences
Johnson & Johnson (J&J) said it will end its COVID-19 vaccine manufacturing deal with Emergent BioSolutions Inc. Both companies have accused the other of breaching their contract, with Emergent saying the drugmaker doesn’t plan to buy the minimum number...
by Jordana Choucair | Jun 7, 2022 | Life Sciences
Pfizer announced that it is investing $120 million to boost production of its Paxlovid COVID-19 treatment pills in the U.S. To date, Pfizer has shipped 12 million courses globally to 37 countries, including 5 million to the U.S. The investment will allow Pfizer to add...
by Jordana Choucair | Jun 6, 2022 | Life Sciences
Prime Therapeutics released a new study suggesting that using a medically-integrated dispensing (MID) model could yield significant savings.Under a MID model, care providers have access to prescribing history, test results, and other patient history in the electronic...
by Jordana Choucair | Jun 6, 2022 | Life Sciences
Abbott Nutrition announced on Saturday that it will resume producing infant formula at its Michigan facility. Abbott said in a statement that initial requirements of the consent agreement it reached with the Food and Drug Administration (FDA) last month had been met,...
Recent Comments